Compare CSBR & TISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSBR | TISI |
|---|---|---|
| Founded | 1985 | 1973 |
| Country | United States | United States |
| Employees | N/A | 6800 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.0M | 76.3M |
| IPO Year | 2015 | 1995 |
| Metric | CSBR | TISI |
|---|---|---|
| Price | $5.78 | $16.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.7K | 3.2K |
| Earning Date | 03-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 161.11 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,900,000.00 | ★ $896,483,000.00 |
| Revenue This Year | $4.84 | N/A |
| Revenue Next Year | $11.51 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 5.19 |
| 52 Week Low | $5.50 | $12.34 |
| 52 Week High | $8.74 | $19.99 |
| Indicator | CSBR | TISI |
|---|---|---|
| Relative Strength Index (RSI) | 44.45 | 50.11 |
| Support Level | $5.66 | $16.62 |
| Resistance Level | $6.31 | $17.10 |
| Average True Range (ATR) | 0.39 | 0.56 |
| MACD | -0.05 | -0.06 |
| Stochastic Oscillator | 19.25 | 43.26 |
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Team Inc provides specialty industrial services, including inspection, engineering assessment, and mechanical repair and remediation required in maintaining high-temperature and high-pressure piping systems and vessels utilized in refining, petrochemicals, and others. The company operates in two segments, Inspection and Heat Treating and Mechanical Services. The Inspection and Heat Treating segment, which generates maximum revenue, provides conventional and non-destructive testing services for the process, pipeline, and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. Geographically, the company derives its key revenue from the United States, followed by other countries, and Canada.